Cmax is the highest concentration a compound reaches after a single dose, and Tmax is the time from intake to that peak. Together they describe the shape of the exposure curve a log entry is trying to reference.
Why it matters for logging
Subjective effect readings often track Tmax more than the moment of dosing. A symptom check at thirty minutes against a compound with a two-hour Tmax will under-report effect. A check at four hours past a one-hour Tmax can miss the peak entirely. Choosing a consistent post-dose check time anchors the comparison and reduces noise that looks like an outcome trend.
What changes the peak and time to peak
Form, food, and route shift both values for the same label dose.
- Liquid and sublingual formats can change Cmax and Tmax compared with a swallowed capsule.
- Fat-containing meals can delay Tmax and may change Cmax for lipid-soluble compounds.
- Timed-release matrices can push Tmax later and lower Cmax in exchange for a flatter curve.
Relation to bioavailability
Bioavailability describes how much of a dose reaches circulation overall. Cmax and Tmax describe how that amount arrives across time. Two products with similar bioavailability can produce very different reported effects when the curve shapes differ.
Dose timing and effect checks
When the gap between a dose and a self-rating shifts day to day, the journal records noise that resembles an outcome change. Locking the check time relative to expected Tmax reduces that artefact. Stable timing is what lets two readings against the same compound stay comparable.
Practical action step
Record the route, food context, and elapsed time at each effect check. If outcomes diverge across products with the same label dose, suspect a Cmax or Tmax difference before assuming a potency change.
Uncertainty and limits
- Tmax estimates are often population averages that hide person-level variability.
- Cmax may shift with physiology and context, including sleep loss, illness, and cycle phase.
Cross-site references
How this appears in Unfair
Unfair uses Cmax and Tmax class data to interpret effect checks after a dose and to warn when a format change may shift the curve enough to mislead a journal comparison.
Clinical safety note
If a new product produces a sharper peak than expected, pause further escalation and reassess route and form before adjusting amount.